First-pass extracted concept

adult astrocytoma

Candidate: concept label1 source documents3 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

adult astrocytomas, IDH1/IDH2-wildtype infiltrating astrocytic gliomas

Evidence Snippets

Adult astrocytomas, particularly IDH1/IDH2-wildtype infiltrating astrocytic gliomas, represent a significant challenge for medical professionals.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2026MEDDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1clinical outcome summarysupports2026Source 1DOI PubMed

Small-molecule tyrosine kinase inhibitors have largely failed to improve survival in adult astrocytoma patients.

Quoted textsource-backed

Although targeted therapies, such as small-molecule tyrosine kinase inhibitors (TKIs), have shown benefits in other solid tumors, they have largely failed to improve survival in adult astrocytoma patients.

Claim 2disease propertysupports2026Source 1DOI PubMed

Adult astrocytomas are characterized by marked heterogeneity and robust drug resistance mechanisms.

Quoted textsource-backed

Characterized by remarkable heterogeneity, these tumors develop robust drug resistance mechanisms.

Claim 3knowledge gapsupports2026Source 1DOI PubMed

The molecular processes driving resistance to small-molecule tyrosine kinase inhibitors in adult astrocytoma are complex and not yet fully understood.

Quoted textsource-backed

The molecular processes driving this resistance are complex and not yet fully understood.